F-Point Validation Study
NCT03623061 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2018-08-09
Summary
The F-Point investigation is an open label, single centre prospective observational study in 3 cohorts of patients, one with low fibrinogen concentration, one with normal fibrinogen concentration, and one with high fibrinogen concentration To show statistical agreement between the fibrinogen level as recorded by the standard lab Clauss fibrinogen, and the fibrinogen level as recorded by the novel F-Point device.
Conditions
- Low Fibrinogen
Interventions
- DIAGNOSTIC_TEST
-
F-Point
F-Point (point of care in vitro diagnostic device for measuring plasma fibrinogen concentration)
Sponsors & Collaborators
-
Dublin City University
collaborator OTHER -
Enterprise Ireland
collaborator OTHER_GOV -
Royal College of Surgeons, Ireland
lead OTHER
Principal Investigators
-
Patrick Thornton · Rotunda Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-14
- Primary Completion
- 2018-10-30
- Completion
- 2018-10-30
Countries
- Ireland
Study Locations
More Related Trials
-
Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.
NCT04671160 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
NCT00843492 ·Status: COMPLETED ·Phase: PHASE3
-
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
NCT03666650 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
NCT00789399 ·Status: TERMINATED ·Phase: NA
-
Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin
NCT04794348 ·Status: WITHDRAWN ·Phase: PHASE2
-
Determination of Residual Anticoagulatory Effects of Fondaparinux
NCT01101256 ·Status: UNKNOWN
-
Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
NCT01615705 ·Status: COMPLETED
-
Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood
NCT01375725 ·Status: COMPLETED
-
Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)
NCT00157677 ·Status: COMPLETED ·Phase: PHASE3
-
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
NCT03083704 ·Status: COMPLETED ·Phase: PHASE1
-
D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs
NCT02341937 ·Status: COMPLETED
-
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2
NCT02371070 ·Status: COMPLETED
-
The 36-month Extension to Follow up Sub Study
NCT01615692 ·Status: WITHDRAWN
-
Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System
NCT05422157 ·Status: COMPLETED
-
Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants
NCT03742336 ·Status: COMPLETED ·Phase: PHASE1
-
High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
NCT02570243 ·Status: COMPLETED ·Phase: PHASE4
-
Fiix-prothrombin Time for Monitoring Warfarin
NCT01565239 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin
NCT00660946 ·Status: COMPLETED
-
Prospective Trial of a Validated Algorithm for Warfarin Dosing
NCT02705976 ·Status: COMPLETED ·Phase: NA
-
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
NCT00555438 ·Status: COMPLETED ·Phase: PHASE4
-
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1
NCT02371044 ·Status: COMPLETED
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants
NCT06582563 ·Status: NOT_YET_RECRUITING
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
NCT02704052 ·Status: COMPLETED ·Phase: EARLY_PHASE1